HK Stock MarketDetailed Quotes
01099 SINOPHARM
- 20.800
- +0.550+2.72%
Not Open Sep 30 16:08 CST
64.91BMarket Cap6.85P/E (TTM)
21.400High20.200Low13.51MVolume20.750Open20.250Pre Close280.95MTurnover1.01%Turnover Ratio6.50P/E (Static)3.12BShares22.90052wk High0.78P/B27.91BFloat Cap16.02052wk Low0.96Dividend TTM1.34BShs Float40.024Historical High0.956Dividend LFY5.93%Amplitude8.756Historical Low20.793Avg Price400Lot Size4.60%Div YieldTTM4.60%Div Yield LFY
SINOPHARM Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -14.32%7.6B | ---- | 5.11%19.51B | ---- | 10.77%8.87B | ---- | 9.18%18.56B | ---- | 3.72%8B | ---- |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | 7.10%-563K | ---- | -206.83%-40.05M | ---- | -13.27%-606K | ---- | -1,278.14%-13.05M | ---- | -9.41%-535K | ---- |
| Attributable subsidiary (profit) loss | -8.78%-624.72M | ---- | -3.78%-1.11B | ---- | -16.51%-574.28M | ---- | 0.26%-1.07B | ---- | -8.35%-492.88M | ---- |
| Impairment and provisions: | 0.72%1.33B | ---- | 5.86%772.55M | ---- | 33.26%1.32B | ---- | -40.61%729.81M | ---- | 36.52%989.38M | ---- |
| -Other impairments and provisions | 0.72%1.33B | ---- | 5.86%772.55M | ---- | 33.26%1.32B | ---- | -40.61%729.81M | ---- | 36.52%989.38M | ---- |
| Revaluation surplus: | -4,251.32%-3.16M | ---- | -377.34%-62.93M | ---- | 100.98%76K | ---- | 59.65%-13.18M | ---- | -27,560.71%-7.75M | ---- |
| -Other fair value changes | -4,251.32%-3.16M | ---- | -377.34%-62.93M | ---- | 100.98%76K | ---- | 59.65%-13.18M | ---- | -27,560.71%-7.75M | ---- |
| Asset sale loss (gain): | -25.42%1.3B | ---- | -57.30%2.21B | ---- | 8,808.00%1.75B | ---- | 499.04%5.17B | ---- | 64.05%-20.04M | ---- |
| -Loss (gain) from sale of subsidiary company | -88.32%-9.43M | ---- | -176.25%-27.74M | ---- | 32.50%-5.01M | ---- | 2,559.50%36.38M | ---- | 36.58%-7.42M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 96.23%-3.39M | ---- | -1,270.30%-235.93M | ---- | -1,804.81%-89.89M | ---- | -907.43%-17.22M | ---- | 88.30%-4.72M | ---- |
| -Loss (gain) from selling other assets | -28.57%1.31B | ---- | -52.02%2.47B | ---- | 23,389.04%1.84B | ---- | 494.62%5.15B | ---- | -111.94%-7.9M | ---- |
| Depreciation and amortization: | 10.73%2.33B | ---- | 6.37%4.43B | ---- | 4.95%2.1B | ---- | 6.19%4.17B | ---- | 6.31%2B | ---- |
| -Depreciation | 14.50%941.11M | ---- | 3.94%1.86B | ---- | -4.61%821.95M | ---- | 6.92%1.79B | ---- | 6.16%861.7M | ---- |
| -Amortization of intangible assets | -17.39%208.41M | ---- | 6.47%415.93M | ---- | 41.25%252.29M | ---- | 2.35%390.66M | ---- | 3.26%178.62M | ---- |
| Financial expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.73%1.76B | ---- |
| Special items | 25.45%-11.13M | ---- | -1.14%-98.92M | ---- | -104.28%-14.93M | ---- | -5.33%-97.81M | ---- | 22.59%348.52M | ---- |
| Operating profit before the change of operating capital | -11.37%11.91B | ---- | -6.65%25.61B | ---- | 6.84%13.44B | ---- | 7.66%27.44B | ---- | 6.22%12.58B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -45.87%-8.88B | ---- | 104.79%455.56M | ---- | -9.67%-6.09B | ---- | -118.72%-9.5B | ---- | -50.80%-5.55B | ---- |
| Accounts receivable (increase)decrease | 19.14%-57.88B | ---- | -1,578.31%-14.96B | ---- | -78.80%-71.58B | ---- | 103.86%1.01B | ---- | 11.66%-40.04B | ---- |
| Accounts payable increase (decrease) | -32.83%16.12B | ---- | -12.40%8.68B | ---- | 691.93%24B | ---- | -50.70%9.91B | ---- | -76.50%3.03B | ---- |
| prepayments (increase)decrease | -103.09%-28.8M | ---- | 165.10%4.89B | ---- | 141.16%933.46M | ---- | -6,060.39%-7.5B | ---- | -528.53%-2.27B | ---- |
| Special items for working capital changes | 135.92%535.61M | ---- | -173.02%-2.93B | ---- | -537.43%-1.49B | ---- | 328.63%4.01B | ---- | 134.03%340.9M | ---- |
| Cash from business operations | 6.06%-38.29B | ---- | -14.25%21.75B | ---- | -27.76%-40.76B | ---- | 89.53%25.36B | ---- | -24.49%-31.9B | ---- |
| Other taxs | -5.35%-2.71B | ---- | -4.01%-4.58B | ---- | -7.46%-2.57B | ---- | -7.98%-4.4B | ---- | -11.64%-2.39B | ---- |
| Adjustment items of business operations | ---- | -16.68%-47.48B | ---- | -26.22%-39.67B | ---- | -11.51%-40.69B | ---- | -2.62%-31.43B | ---- | -4.74%-36.49B |
| Net cash from operations | 5.38%-40.99B | -16.68%-47.48B | -18.08%17.17B | -26.22%-39.67B | -26.34%-43.33B | -11.51%-40.69B | 125.22%20.96B | -2.62%-31.43B | -23.50%-34.29B | -4.74%-36.49B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 2.72%39.72M | ---- | 145.31%182.9M | ---- | -2.94%38.67M | ---- | -11.99%74.56M | ---- | -11.41%39.84M | ---- |
| Dividend received - investment | 309.39%245.03M | 29.46%12.54M | -25.79%419.34M | -34.28%171.5M | -40.13%59.85M | -62.27%9.68M | 29.62%565.09M | 334.55%260.97M | 76.25%99.97M | 173.07%25.67M |
| Restricted cash (increase) decrease | -100.27%-4.8M | ---- | 105.83%102.91M | ---- | 54.58%1.76B | ---- | -415.16%-1.76B | ---- | 22.01%1.14B | ---- |
| Sale of fixed assets | 85.47%92.91M | 717.81%44.86M | 164.67%456.13M | 1,127.92%347.35M | 20.02%50.09M | -12.59%5.49M | 28.60%172.34M | 90.67%28.29M | -23.82%41.74M | 187.84%6.27M |
| Purchase of fixed assets | -42.23%-1.02B | -16.41%-473.1M | 7.88%-1.96B | 8.18%-1.35B | 17.32%-719.37M | 5.02%-406.41M | -2.57%-2.13B | -8.98%-1.47B | -9.86%-870.08M | -14.21%-427.89M |
| Selling intangible assets | -30.07%16.32M | ---- | 4,467.04%209.08M | ---- | 148.54%23.33M | ---- | -21.45%4.58M | ---- | 61.43%9.39M | ---- |
| Purchase of intangible assets | -98.84%-273.35M | ---- | -29.58%-376.28M | ---- | -161.26%-137.47M | ---- | -59.79%-290.39M | ---- | 13.68%-52.62M | ---- |
| Sale of subsidiaries | -0.74%43.87M | ---- | -15.40%99.2M | ---- | 324.06%44.19M | ---- | 533.76%117.26M | ---- | -51.10%10.42M | ---- |
| Acquisition of subsidiaries | -183.82%-103.51M | -271.22%-97.04M | 71.13%-131.05M | 28.05%-74.4M | 78.27%-36.47M | ---26.14M | 10.44%-453.97M | 50.35%-103.4M | 28.68%-167.82M | ---- |
| Recovery of cash from investments | -176.23%-71.52M | 380.39%60.16M | -74.91%53.23M | 122.57%32.05M | -32.50%93.81M | --12.52M | -29.22%212.16M | -92.69%14.4M | 141.73%138.98M | ---- |
| Cash on investment | ---41K | 89.33%-4.92M | 99.58%-422K | 49.25%-90.57M | ---- | -62.76%-46.17M | -33.33%-100M | 68.59%-178.46M | ---66K | 2.45%-28.37M |
| Other items in the investment business | ---- | -17.69%713.63M | ---- | 124.68%978.9M | ---326K | 70.95%867.04M | ---- | -78.12%435.68M | ---- | -46.80%507.18M |
| Net cash from investment operations | -187.97%-1.04B | -38.43%256.12M | 73.69%-944.54M | 101.27%12.85M | 201.89%1.18B | 402.02%416.01M | -183.33%-3.59B | -849.60%-1.01B | 342.82%391.03M | -78.32%82.87M |
| Net cash before financing | 0.27%-42.03B | -17.25%-47.23B | -6.59%16.23B | -22.24%-39.66B | -24.32%-42.15B | -10.62%-40.28B | 116.07%17.37B | -6.40%-32.44B | -22.48%-33.9B | -5.66%-36.41B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -12.12%54.49B | -9.95%33.39B | 4.63%93.29B | 7.23%97.25B | 13.87%62.01B | 27.18%37.09B | 12.97%89.16B | 5.51%90.69B | 9.94%54.45B | -25.76%29.16B |
| Refund | -1.18%-35.35B | 16.81%-17.83B | 2.07%-82.95B | 1.10%-69.57B | -6.61%-34.94B | -50.20%-21.43B | -4.74%-84.7B | 5.32%-70.34B | 11.24%-32.77B | 51.34%-14.27B |
| Issuance of bonds | 32.23%8.99B | ---- | -23.95%13.15B | ---- | 7.94%6.8B | ---- | -17.67%17.29B | ---- | -56.54%6.3B | ---- |
| Interest paid - financing | -1.64%-1.44B | ---- | 33.05%-3.2B | ---- | 23.17%-1.42B | ---- | -4.43%-4.78B | ---- | 5.75%-1.85B | ---- |
| Dividends paid - financing | 10.49%-1.01B | 5.31%-1.11B | -20.59%-4.83B | -12.67%-7.52B | -39.57%-1.13B | -14.36%-1.17B | -3.94%-4.01B | -3.04%-6.67B | 22.20%-809.18M | 1.91%-1.02B |
| Absorb investment income | 295.28%136.78M | 330.71%59.88M | -44.51%120.85M | -48.51%94.42M | -76.43%34.6M | -78.49%13.9M | -57.14%217.81M | -56.51%183.36M | -38.69%146.78M | -40.86%64.63M |
| Issuance expenses and redemption of securities expenses | 66.67%-3B | ---- | -23.43%-20.99B | ---- | -350.00%-9B | ---- | 28.68%-17B | ---- | 82.67%-2B | ---- |
| Other items of the financing business | ---- | 15.50%7.64B | -157.47%-118.13M | -166.71%-2.57B | -141.32%-33.16M | 14.14%6.61B | 79.81%-45.88M | 922.68%3.85B | 85.00%-13.74M | 34.05%5.79B |
| Net cash from financing operations | 1.20%21.55B | 4.94%22.15B | -34.26%-7.64B | -0.16%17.69B | -5.41%21.3B | 7.03%21.11B | 61.25%-5.69B | 244.48%17.71B | 89.82%22.51B | 47.85%19.72B |
| Effect of rate | -33.11%3.65M | 112.76%651.16K | -79.25%2.39M | -67.16%9.25M | 0.76%5.46M | -269.17%-5.1M | 277.81%11.51M | 1,140.96%28.17M | 393.98%5.42M | -200.95%-1.38M |
| Net Cash | 1.77%-20.48B | -30.80%-25.07B | -26.51%8.58B | -49.17%-21.97B | -83.07%-20.85B | -14.87%-19.17B | 275.60%11.68B | 41.90%-14.73B | 28.01%-11.39B | 21.00%-16.69B |
| Begining period cash | 15.55%63.81B | 14.56%63.81B | 26.86%55.22B | 26.86%55.22B | 26.86%55.22B | 27.68%55.7B | -13.25%43.53B | -13.25%43.53B | -13.25%43.53B | -13.24%43.62B |
| Cash at the end | 26.05%43.33B | 6.05%38.74B | 15.55%63.81B | 15.37%33.26B | 6.94%34.38B | 35.61%36.53B | 26.86%55.22B | 16.12%28.83B | -6.44%32.15B | -7.64%26.94B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data